Peptide Based Injectable Drugs Market Set to Boom Rapidly by 2033| Amgen • Eli Lilly and Company • Novo Nordisk • Sanofi

AI Briefing

• – Peptide-based injectable drugs market expected to grow rapidly, driven by increasing demand for innovative treatments, major pharmaceutical companies investing heavily in research and development, and expanding applications in various therapeutic areas.
• – Key players such as Amgen, Eli Lilly and Company, Novo Nordisk, and Sanofi are expected to dominate the market, with Amgen's enbrel and Eli Lilly's solrestrol being notable examples of successful peptide-based injectable drugs.
• – Report highlights emerging trends, including the increasing use of peptide-based injectable drugs in treating rare genetic disorders and the growing need for targeted therapies in oncology and immunology.